Stereotaxis Inc Stock Nasdaq
Equities
US85916J4094
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 30.88M | Sales 2025 * | 44.25M | Capitalization | 195M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -16M | EV / Sales 2024 * | 6.33 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.42 x |
P/E ratio 2024 * |
-10.1
x | P/E ratio 2025 * |
-12.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.12% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 16-09-28 | |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 02-12-31 |
Laura Garth
LAW | General Counsel | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 05-04-30 |
Chief Executive Officer | 57 | 16-09-28 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 17-02-02 |
1st Jan change | Capi. | |
---|---|---|
+8.78% | 220B | |
+8.24% | 185B | |
+11.16% | 133B | |
+26.12% | 107B | |
+0.61% | 62.91B | |
+16.21% | 53.34B | |
-1.63% | 47.71B | |
-1.11% | 40.29B | |
+12.16% | 39.57B |